Table 5 Quality scores of the Hungarian version of the ID-Migraine questionnaire in the clinically relevant subgroups
From: The validation of the Hungarian version of the ID-migraine questionnaire
N (%) | Sensitivity(95% CI) | Specificity (95% CI) | PPV (95% CI) | NPV (95% CI) | Classification error (95% CI) | |
|---|---|---|---|---|---|---|
Sex | ||||||
Women | 304 (80%) | 0.95 (0.92–0.97) | 0.47 (0.30–0.65) | 0.93 (0.90–0.96) | 0.55 (0.36–0.73) | 0.1 (0.07–0.14) |
Men | 76 (20%) | 0.95 (0.81–0.99) | 0.39 (0.24–0.56) | 0.63 (0.49–0.75) | 0.88 (0.60–0.98) | 0.32 (0.22–0.44) |
Age | ||||||
≤ 44 years | 262 (69%) | 0.96 (0.92–0.98) | 0.44 (0.29–0.60) | 0.89 (0.84–0.93) | 0.69 (0.48–0.85) | 0.13 (0.09–0.18) |
> 44 years | 118 (31%) | 0.94 (0.86–0.98) | 0.48 (0.27–0.69) | 0.87 (0.78–0.93) | 0.69 (0.41–0.88) | 0.16 (0.10–0.24) |
Duration of illness | ||||||
≤ 12 years | 228 (60%) | 0.96 (0.89–0.99) | 0.41 (0.25–0.59) | 0.82 (0.74–0.89) | 0.78 (0.52–0.93) | 0.18 (0.12–0.26) |
> 12 years | 152 (40%) | 0.94 (0.85–0.98) | 0.33 (0.09–0.69) | 0.93 (0.84–0.97) | 0.38 (0.10–0.74) | 0.13 (0.06–0.21) |